Evidence map›Paper›PMID 38409099›Full record

ArticleAllergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology2024

The chronic rhinosinusitis with nasal polyp patient journey in the United States and Europe.

Jeremiah Hwee, Lauren Lee, Mark Small, Steven G Smith, Victoria S Benson, Shiyuan Zhang

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. A patient-centric approach to chronic rhinosinusitis with nasal polyps (CRSwNP): developing tools to improve disease management and outcomes.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Jeremiah HweeValue Evidence and Outcomes, GSK, Mississauga, ON, Canada. jeremiah.x.hwee@gsk.com.ORCID http://orcid.org/0000-0002-2623-7706
Lauren LeeAdelphi Real World, Bollington, Cheshire, UK.
Mark SmallAdelphi Real World, Bollington, Cheshire, UK.
Steven G SmithClinical Sciences, GSK, Durham, NC, USA.
Victoria S BensonEpidemiology, Value Evidence and Outcomes, GSK, Brentford, Middlesex, UK.
Shiyuan ZhangValue Evidence and Outcomes, GSK, Collegeville, PA, USA.
Adelphi Group (United Kingdom) · GBGlaxoSmithKline (Canada) · CAGlaxoSmithKline (United States) · US

Funding

GSK Study Numbers: 208086 and 213369
6 · The paper itself

Abstract

In this letter to the editor, we present questionnaire-based data assessing the patient journey of adults with moderate-severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in the USA and five European countries. These data highlight how long and difficult the patient journey with CRSwNP can be and how improved disease awareness among physicians could lead to more timely diagnosis and treatment, and hence improved management of patients.

Indexed as

Chronic RhinosinusitisNasal polypsQuality of lifeSmell

Identifiers

PMID38409099
PMCPMC10898083
OpenAlexW4392168640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.